搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Aeropyrum pernix Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B (gatB) CSB-YP897376AYB
CSB-EP897376AYB
CSB-BP897376AYB
CSB-MP897376AYB
CSB-EP897376AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix Aspartate carbamoyltransferase regulatory chain (pyrI) CSB-YP897377AYB
CSB-EP897377AYB
CSB-BP897377AYB
CSB-MP897377AYB
CSB-EP897377AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (apgM) CSB-YP897378AYB
CSB-EP897378AYB
CSB-BP897378AYB
CSB-MP897378AYB
CSB-EP897378AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix Acylamino-acid-releasing enzyme (APE_1547.1), partial CSB-YP897379AYB
CSB-EP897379AYB
CSB-BP897379AYB
CSB-MP897379AYB
CSB-EP897379AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix UPF0273 protein APE_1505.1 (APE_1505.1) CSB-YP897380AYB
CSB-EP897380AYB
CSB-BP897380AYB
CSB-MP897380AYB
CSB-EP897380AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix N-acetyl-gamma-glutamyl-phosphate/N-acetyl-gamma-aminoadipyl-phosphate reductase (argC) CSB-YP897381AYB
CSB-EP897381AYB
CSB-BP897381AYB
CSB-MP897381AYB
CSB-EP897381AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix 50S ribosomal protein L37Ae (rpl37ae) CSB-YP897382AYB
CSB-EP897382AYB
CSB-BP897382AYB
CSB-MP897382AYB
CSB-EP897382AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP897383AYB
CSB-EP897383AYB
CSB-BP897383AYB
CSB-MP897383AYB
CSB-EP897383AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix 30S ribosomal protein S3Ae (rps3Ae) CSB-YP897384AYB
CSB-EP897384AYB
CSB-BP897384AYB
CSB-MP897384AYB
CSB-EP897384AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix Putative ribonuclease VapC3 (vapC3) CSB-YP897385AYB
CSB-EP897385AYB
CSB-BP897385AYB
CSB-MP897385AYB
CSB-EP897385AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix Translation initiation factor 6 (eif6) CSB-YP897386AYB
CSB-EP897386AYB
CSB-BP897386AYB
CSB-MP897386AYB
CSB-EP897386AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix 50S ribosomal protein L14e (rpl14e) CSB-YP897387AYB
CSB-EP897387AYB
CSB-BP897387AYB
CSB-MP897387AYB
CSB-EP897387AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix Mannosyl-3-phosphoglycerate synthase (mngA) CSB-YP897388AYB
CSB-EP897388AYB
CSB-BP897388AYB
CSB-MP897388AYB
CSB-EP897388AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix Heme-copper oxidase subunit 4 (aoxC), partial CSB-YP897389AYB1
CSB-EP897389AYB1
CSB-BP897389AYB1
CSB-MP897389AYB1
CSB-EP897389AYB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix Putative HTH-type transcriptional regulatory protein APE_0778 (APE_0778) CSB-YP897390AYB
CSB-EP897390AYB
CSB-BP897390AYB
CSB-MP897390AYB
CSB-EP897390AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix N-glycosylase/DNA lyase (APE_0710.1) CSB-YP897391AYB
CSB-EP897391AYB
CSB-BP897391AYB
CSB-MP897391AYB
CSB-EP897391AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix Shikimate kinase (aroK) CSB-YP897392AYB
CSB-EP897392AYB
CSB-BP897392AYB
CSB-MP897392AYB
CSB-EP897392AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix 50S ribosomal protein L13e (rpl13e) CSB-YP897393AYB
CSB-EP897393AYB
CSB-BP897393AYB
CSB-MP897393AYB
CSB-EP897393AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix Ribosomal RNA small subunit methyltransferase Nep1 (nep1) CSB-YP897394AYB
CSB-EP897394AYB
CSB-BP897394AYB
CSB-MP897394AYB
CSB-EP897394AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aeropyrum pernix Cell division control protein 6 homolog (cdc6) CSB-YP897395AYB
CSB-EP897395AYB
CSB-BP897395AYB
CSB-MP897395AYB
CSB-EP897395AYB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>